Nartikova V F, Paskhina T S
Vopr Med Khim. 1979 Jul-Aug;25(4):494-9.
A modified spectrophotometric method is developed for simultaneous estimation of alpha 1-antitrypsin and alpha 2-macroglobulin in human blood serum (plasma); the method is based on dissimilar interaction of these inhibitors with trypsin in the systems with a low molecular substrate N-alpha-benzoyl-l-arginine ethyl ester. alpha 1-Antitrypsin was estimated by inhibition of the arginine esterase activity of trypsin in a mixture containing human blood serum diluted 50-fold. alpha 2-Macroglobulin was estimated by maintained arginine esterase activity of the trypsin-alpha 2-macroglobulin complex, formed after interaction of an excess of trypsin with blood serum, diluted 10-fold and after subsequent inactivation of free, unbound with alpha 2-macroglobulin, trypsin by treatment with the soy bean inhibitor of trypsin. alpha 1-Antitrypsin and alpha 2-macrog-obulin were estimated by means of the method described in blood serum of healthy persons and in patients with burns or with carcinoma of pancreas. The method enables to estimate two main inhibitors of blood plasma proteinases in a small volume of blood serum (0.1 ml) very rapidly and specifically using commercially available substrate; the method might be recommended for routine clinical analysis.
开发了一种改进的分光光度法,用于同时测定人血清(血浆)中的α1 - 抗胰蛋白酶和α2 - 巨球蛋白;该方法基于这些抑制剂在含有低分子底物N-α-苯甲酰-L-精氨酸乙酯的体系中与胰蛋白酶的不同相互作用。通过在稀释50倍的人血清混合物中抑制胰蛋白酶的精氨酸酯酶活性来测定α1 - 抗胰蛋白酶。通过胰蛋白酶-α2 - 巨球蛋白复合物的精氨酸酯酶活性来测定α2 - 巨球蛋白,该复合物是在过量胰蛋白酶与稀释10倍的血清相互作用后形成的,随后用大豆胰蛋白酶抑制剂处理使未与α2 - 巨球蛋白结合的游离胰蛋白酶失活。通过所述方法在健康人的血清以及烧伤或胰腺癌患者的血清中测定α1 - 抗胰蛋白酶和α2 - 巨球蛋白。该方法能够使用市售底物在少量血清(0.1 ml)中非常快速且特异性地测定血浆蛋白酶的两种主要抑制剂;该方法可推荐用于常规临床分析。